Our group was the first to demonstrate the effect of GH locally applied on the peri-implant bone reaction in an experimental animal model, both under osteoporotic conditions (22) and without osteoporosis (40,41), obtaining an improvement in peri-implant osteogenesis and higher BIC, 15 days after implant placement, with local GH treatment. Here, GH1 is linked to osteoporosis.